Arcturus Therapeutics Holdings (ARCT) executive compensation, 2026 proxy

Joseph E. Payne, President and Chief Executive Officer, Director, was paid $1.7M in 2025, down 54% from $3.7M the year before.

Filed
April 24, 2026
Annual meeting
June 5, 2026
Pay year
2025
Named executives
5
CEO total pay
$1.7M-54% vs prior year
Prior say-on-pay support
97%of votes cast
CEO Target Bonus Percentage
60%Of annual base salary
Say-on-Pay Support
96.9%From June 2025 meeting
CEO Stock Options Granted
175,000Shares underlying options in 2025
Median Employee Total Pay
$208,500For fiscal year 2025

How Payne was paid

$1.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary44%Option awards56%

Named executive officers

ExecutiveTotal
Joseph E. PaynePresident and Chief Executive Officer, Director$1,691,000
Dr. Padmanabh ChivukulaChief Scientific Officer, Chief Operating Officer$862,000
Andy SassineFormer Chief Financial Officer$1,181,500
Lance KurataChief Legal Officer$830,000
Joe RobertsInterim Principal Financial Officer and Accounting Officer; Controller$273,580

What changed and why

  • 54%CEO total compensation for 2025 was 1691000 dollars, reflecting a 54 percent decrease compared to 2024.
  • No cash bonuses were awarded to named executive officers for the 2025 fiscal year.
  • Andy Sassine stepped down as Chief Financial Officer and received severance payments totaling 572000 dollars.
  • Stock option awards granted to the CEO in December 2025 totaled 941000 dollars in grant date fair value.
  • 96.9%At the 2025 annual meeting, approximately 96.9 percent of votes cast supported the say-on-pay proposal.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.